Quinalbarbitone (Na)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Quinalbarbitone (Na) is a is a short-acting barbiturate derivative drug that was patented in 1934 in the United States.It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as Quinalbarbitone. Quinalbarbitone (Na) is used in the treatment of anxiety and insomnia.
Indications
Quinalbarbitone (Na) is primarily indicated in conditions like Insomnia.
Contraindications
Quinalbarbitone (Na) is contraindicated in conditions like Pain, Porphyrias, Liver disease, Severe respiratory disease, Renal impairment, Sleep apnea, Alcoholism, Drug dependence, Suicidal tendencies.
Side Effects
The severe or irreversible adverse effects of Quinalbarbitone (Na), which give rise to further complications include Nystagmus, Respiratory depression, Myalgia, Neuralgia, Arthritic pain, Slurred speech, Somnolence, Semicoma, Shock. Quinalbarbitone (Na) produces potentially life-threatening effects which include Carcinogenicity, Unconsciousness. which are responsible for the discontinuation of Quinalbarbitone (Na) therapy.The signs and symptoms that are produced after the acute overdosage of Quinalbarbitone (Na) include Hypotension, Respiratory depression, Hypothermia, Miosis, Cardiodepression, Oliguria, Mydriasis. The symptomatic adverse reactions produced by Quinalbarbitone (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Ataxia, Restlessness, Confusion, Vertigo, Sedation, Euphoria, Somnolence, Dizziness, Headache, Constipation, irritability, nightmares, Bleeding, Fever, Rash.
Warnings
Avoid Quinalbarbitone in patients with porphyria.
High Risk Groups
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.71 to 2.86 mg/kg (1.8 (1.785)) 24 hourly PO — As Required
Child Dosage
Should not be used in children ( ) —
Neonatal Dosage
Should not be used in children ( ) —
Drug Interactions
No data regarding the interactions of Quinalbarbitone (Na) was found.
Storage
Cap, Elixir, Inj Protect from Sunlight.
Available Brands in Pakistan
No brands are recorded for this generic.